As we all know the JP Morgan Healthcare
conference is an invitation-only conference. For this reason, I have summarized
various announcements for the purpose of this review. As we have witnessed in
the past, exciting announcements happen here in San Francisco around or just
before this annual conference, and some of the news spark what eventually will
become the big trends throughout the year. One could say it is a window to what
is just around the corner in 2019.
Several commercial tool providers and
diagnostic companies used this venue to announce their strategies or to provide
a status update:
Qiagen announced that they will acquire N-of-One. The addition of N-of-One will enable QIAGEN to significantly expand its decision-support solutions while offering a broader range of software, content with access to the MarkerMine™ database, and service-based solutions.
This year’s Bio-IT conference – with theme Big Data – was clearly marked by the presence of clinical genetics: its data sharing, analysis, and interpretation challenges echoed throughout the many talks (and exhibit) whether it was Heidi Rhem’s opening plenary session or George Church’s genomics breakfast session, demonstrating that routine sequencing is within reach. Undoubtedly, there have been great developments in the software space in the past years, but scaling for massive genomics data still requires work! Interestingly, overlapping with Bio-IT 2016, the 13th International Congress of Human Genetics held in Kyoto further exemplified what was communicated Continue reading →